Treatment of hyperthyroidism with radioactive iodine

Endocrinology and Metabolism Clinics of North America

Volumn 27, Issue 1, 1998, Pages 205-223

  Kaplan, M M ^a   Meier, D A ^a   Dworkin, H J ^a  

^a Associated Endocrinologists   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; RADIOACTIVE IODINE;

DRUG EFFICACY; DRUG SAFETY; DRUG UPTAKE; EYE DISEASE; FERTILITY; HIGH RISK POPULATION; HUMAN; HYPERTHYROIDISM; PREGNANCY; PRIORITY JOURNAL; RADIATION EXPOSURE; REVIEW; THYROID CANCER;

EID: 0031941970     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(05)70307-8     Document Type: Article

References (78)

1. Y. Aizawa K. Yoshida N. Kaise Frequency and significance of transient hyperthyroidism after radioiodine ablation for Graves' hyperthyroidism Clin Endocrinol (Oxf) 46 1997 1 5
2. R.S. Bahn A.E. Heufelder Pathogenesis of Graves' ophthalmopathy N Engl J Med 329 1993 1468 1475
3. L. Bartalena C. Marcocci F. Bogazzi Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism N Engl J Med 321 1989 1349 1352
4. F.K. Bauer B. Catz Radioactive iodine therapy for progressive malignant exophthalmos Acta Endocrinol 51 1966 15 22
5. D.V. Becker J.R. Hurley Radioiodine treatment of hyperthyroidism M.P. Sandler R.E. Coleman F.J.T. Wackers Diagnostic Nuclear Medicine 1996 Williams & Wilkins New York 943 958
6. D.V. Becker W.M. McConahey B.M. Dobyns The results of radioiodine treatment of hyperthyroidism. A preliminary report of the Thyrotoxicosis Therapy Follow-up Study K. Fellinger R. Hofer Further Advances in Thyroid Research vol 1 1971 Verlage der Wiener Medizinischen Akademie Vienna 603 609
7. D.V. Becker C.T. Sawin Radioiodine and thyroid disease: The beginning Semin Nucl Med 26 1996 155 164
8. G.E.B. Berg A.M.K. Michanek E.C.V. Holmberg Iodine-131 treatment of hyperthyroidism: Significance of effective half-life measurements J Nucl Med 36 1996 228 232
9. A. Bockisch T. Jamitzky R. Derwanz Optimized dose planning of radioiodine therapy of benign thyroidal diseases J Nucl Med 34 1993 1632 1638
10. H.B. Burch B.L. Solomon L. Wartofsky Discontinuing antithyroid drug therapy before ablation with radioiodine in Graves' disease Ann Intern Med 121 1994 553 559
11. H.B. Burch L. Wartofsky Graves' ophthalmopathy: Current concepts regarding pathogenesis and management Endocr Rev 14 1993 747 793
12. J. Clerc M. Izembart F. Dagousset Influence of dose selection on absorbed dose profiles in radioiodine treatment of diffuse toxic goiters in patients receiving or not receiving carbimazole J Nucl Med 34 1993 387 393
13. D.S. Cooper Antithyroid drugs and radioiodine therapy: A grain of (iodized) salt Ann Intern Med 121 1994 612 614
14. D.S. Cooper Treatment of thyrotoxicosis L.E. Braverman R.D. Utiger Werner and Ingbar's The Thyroid. A Fundamental and Clinical Text ed 7 1996 Lippincott-Raven Philadelphia 708 734
15. L.J. DeGroot Radioiodine and the immune system Thyroid 7 1997 259 264
16. L.J. DeGroot C.A. Gorman A. Pinchera Therapeutic controversies: Radiation and Graves' ophthalmopathy J Clin Endocrinol Metab 80 1995 342 345
17. L.J. DeGroot P.R. Larsen G. Hennemann Graves' disease: Diagnosis and treatment The Thyroid and Its Diseases ed 6 1996 Churchill Livingstone New York 417 458
18. B.M. Dobyns G.E. Sheline J.B. Workman Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: A report of the Cooperative Thyrotoxicosis Therapy Follow-up Study Clin Endocrinol Metab 38 1974 976 998
19. J.T. Dunn Choice of therapy in young adults with hyperthyroidism of Graves' disease Ann Intern Med 100 1984 891 893
20. 131I therapy for Thyrotoxicosis: Towards 2000 1993 European Thyroid Association Penarth, Wales
21. T.C. Evans R.M. Kretzchmer R.E. Hodges Radioiodine uptake studies of the human fetal thyroid J Nucl Med 8 1967 157 165
22. Food and Nutrition Board Committee on Dietary Allowances US National Research Council: Iodine Recommended Dietary Allowances ed 10 1989 National Academy Press Publishers Washington, DC 213
23. J.A. Franklyn The management of hyperthyroidism N Engl J Med 130 1994 1731 1738
24. E. Gallegos D.A. Meier M. Garcia Graves' disease triggered by autoinfarction of an autonomously functioning thyroid adenoma J Nucl Med 38 1997 260 262
25. M. Garcia H.J. Baskin S. Feld AACE clinical practice guidelines for the evaluation and treatment of hypothyroidism and hypothyroidism Endocr Pract 1 1995 54 62
26. D. Glinoer D. Hesch R. LaGasse The management of hyperthyroid due to Graves' disease in Europe in 1986: Results of an international survey Acta Endocrinol 185 suppl 1987 9 37
27. 131I or surgical treatment for toxic thyroid adenoma Ann Intern Med 89 1978 85 90
28. G.D. Graham K.D. Burman Radioiodine treatment of Graves disease: An assessment of its potential risks Ann Intern Med 105 1985 900 905
29. F. Hagen R.P. Ouelette E.M. Chapman Comparison of high and low dosage levels of 131-I in the treatment of thyrotoxicosis N Engl J Med 277 1967 559 562
30. P. Hall L.E. Holm Late consequences of radioiodine for diagnosis and therapy in Sweden Thyroid 7 1997 205 208
31. J.I. Hamburger S.W. Hamburger Diagnosis and management of large toxic multinodular goiters J Nucl Med 26 1985 888 892
32. 131I uptake in inoperable thyroid cancer N Engl J Med 280 1969 1091 1094
33. L. Hegedüs H. Perrild L.R. Poulsen The determination of thyroid volume by ultrasound and its relationship to body weight, age, and sex in normal subjects J Clin Endocrinol Metab 56 1983 260 263
34. J.V. Hennessey L.A. Berg M.A. Ibrahim Evaluation of early (5 to 6 hours) iodine 123 uptake for diagnosis and treatment planning in Graves' disease Arch Intern Med 155 1995 621 624
35. R.E. Hodges T.C. Evans J.T. Bradbury The accumulation of radioactive iodine by human fetal thyroids J Clin Endocrinol Metab 15 1955 661 665
36. D.A. Hoffman Late effects of I-131 therapy in the United States J.D. Boice Jr J.F. Fraumeni Jr Radiation Carcinogenesis: Epidemiology and Biological Significance 1984 Raven Press New York 273 280
37. J.R. Hurley Thyroiditis Dis Mon 24 1977 1 68
38. D. Huysmans A. Hermus M. Edelbroek Radioiodine for nontoxic multinodular goiter Thyroid 7 1997 235 239
39. D.A. Huysmans F.H. Corstens P.W. Kloppenberg Long-term follow-up in toxic solitary autonomous thyroid nodules treated with radioactive iodine J Nucl Med 32 1991 27 30
40. D.A.K.C. Huysmans A.R.M.M. Hermus F.H.M. Corstens Large compressive goiters treated with radioiodine Ann Intern Med 121 1994 757 762
41. A.W.C. Kung C.C. Yau A. Cheng The incidence of ophthalmopathy after radioiodine therapy for Graves' disease: Prognostic factors and the role of methimazole J Clin Endocrinol Metab 79 1994 542 546
42. M. Lakshmanan A. Schaffer Robbins A simplified low iodine diet in I-131 scanning and therapy of thyroid cancer Clin Nucl Med 13 1988 866 868
43. C. Marcocci L. Bartelena F. Bogazzi Relationship between Graves' ophthalmopathy and type of treatment of Graves' hyperthyroidism Thyroid 2 1992 171 178
44. H.R. Maxon S.R. Thomas A. Boehringer Low iodine diet ablation of thyroid remnants Clin Nucl Med 8 1983 123 126
45. M.T. McDermott G.S. Kidd L.E. Dodson Jr Radioiodine induced thyroid storm: Case report and literature review Am J Med 75 1983 353 359
46. J.I. Mechanick T.F. Davies Medical management of hyperthyroidism: Theoretical and practical aspects S.A. Falk Thyroid Disease ed 2 1997 Lippincott-Raven Philadelphia 253 296
47. D.A. Meier H.J. Dworkin The autonomously functioning thyroid nodule J Nucl Med 32 1991 30 32
48. Y. Murakami J. Takamatsu S. Sakane Changes in thyroid volume in response to radioactive iodine for Graves' hyperthyroidism correlated with activity of thyroid-stimulating antibody and treatment outcome J Clin Endocrinol Metab 81 1996 3257 3260
49. Y. Nagayama M. Izumi S. Nagataki Management of hyperthyroidism due to Graves' disease in Japan in 1988 Endocrinol Japan 36 1989 299 314
50. 131I treatment in patients with nontoxic goiter J Clin Endocrinol Metab 82 1997 2926 2930
51. K. Peterson C. Bengtsson L. Lapidus Morbidity, mortality and quality of life for patients treated with levothyroxine Arch Intern Med 150 1990 2077 2081
52. M.F. Prummel M.P. Mourits A. Berghout Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy N Engl J Med 321 1989 1353 1359
53. E.H. Quimby S. Feitelberg W. Gross Radioactive Nuclides in Medicine and Biology 1970 Lea and Feibiger New York 28
54. E.L. Saenger G.E. Thoma E.A. Tompkins Incidence of leukemia following treatment of hyperthyroidism: Preliminary report of the Cooperative Thyrotoxicosis Therapy Follow-up Study JAMA 205 1968 855 862
55. A.M. Safa P.G. Skillern Treatment of hyperthyroidism with a large initial dose of sodium iodide I-131 Arch Intern Med 135 1975 673 675
56. 131I for thyroid cancer J Nucl Med 17 1976 460 464
57. J.S.A. Sawers A.D. Toft W.J. Irvine Transient hypothyroidism after iodine-131 treatment of thyrotoxicosis J Clin Endocrinol Metab 50 1980 226 229
58. C.T. Sawin D.V. Becker Radioiodine and the treatment of hyperthyroidism: The early history Thyroid 7 1997 163 176
59. 131I therapy for hyperthyroidism Clin Endocrinol (Oxf) 6 1977 329 332
60. M. Schlumberger F. DeVathaire C. Ceccarelli Exposure to radioactive iodine-131 for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients J Nucl Med 37 1996 606 612
61. R.B. Shafer F.Q. Nuttall Acute changes in thyroid function in patients treated with radioactive iodine Lancet 2 1975 635 637
62. B. Shapiro Optimization of radiodine therapy of thyrotoxicosis: What have we learned after 50 years? J Nucl Med 34 1993 1638 1641
63. S.I. Sherman L. Simonson P.W. Ladenson Clinical and socioeconomic predispositions to complicated thyrotoxicosis: A predictable and preventable syndrome? Am J Med 101 1996 192 198
64. P.A. Singer D.S. Cooper E.G. Levy Treatment guidelines for patients with hyperthyroidism and hypothyroidism JAMA 273 1995 808 812
65. Society of Nuclear Medicine Guidelines for Patients Receiving Radioiodine Treatment 1991 Society of Nuclear Medicine New York 1 7
66. B. Solomon D. Glinoer R. Lagasse Current trends in the management of Graves' disease J Clin Endocrinol Metab 70 1990 1518 1524
67. 131I therapy for hyperthyroidism in the first trimester of pregnancy J Nucl Med 17 1976 146 149
68. L. Tallstedt G. Lundell Radioiodine treatment, ablation, and ophthalmopathy: A balanced perspective Thyroid 7 1997 241 245
69. L. Tallstedt G. Lundell H. Blomgren Does early administration of thyroxine reduce the development of Graves' ophthalmopathy after radioiodine treatment? Eur J Endocrinol 130 1994 494 497
70. E.I. Tamagna G.A. Levine J.M. Hershman Thyroid-hormone concentrations after radioactive iodine therapy for hyperthyroidism J Nucl Med 20 1979 387 391
71. T. Tominaga N. Yokoyama S. Nagataki International differences and approaches to I-131 therapy for Graves' disease: Case selection and restrictions recommended to patients in Japan, Korea and China Thyroid 7 1997 217 220
72. R.M. Tuttle T. Patience S. Budd Treatment with propylthiouracil before radioactive iodine therapy is associated with a higher treatment failure rate than therapy with radioactive iodine alone in Graves' disease Thyroid 5 1995 243 247
73. US Nuclear Regulatory Commission, Division of Regulatory Applications Regulatory analysis on criteria for the release of patients administered radioactive material 1997 US Nuclear Regulatory Commission Washington, DC NUREG-1492
74. US Nuclear Regulatory Commission, Office of Nuclear Regulatory Research: Release of patients administered radioactive materials. Washington, DC, US Nuclear Regulatory Commission Regulatory Guide 8.39, 1997
75. H.L. Uy C.A. Reasner M.H. Samuels Pattern of recovery of the hypothalamic-pituitary-thyroid axis following radioactive iodine therapy in patients with Graves' disease Am J Med 99 1995 173 179
76. R. Volpé Autoimmune thyroiditis G.N. Burrow J.H. Oppenheimer R. Volpé Thyroid Function and Disease 1989 WB Saunders Philadelphia 191 207
77. L. Wartofsky Radioiodine therapy for Graves' disease: Case selection and restrictions recommended to patients in North America Thyroid 7 1997 213 216
78. P.H. Wise A. Ahmad R.B. Burnet Intentional radioiodine ablation of Graves' disease Lancet 2 1975 1231 1232